Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.003 AUD | +20.00% |
|
+50.00% | -14.29% |
16/05 | Avecho Biotechnology Doses First Patient in Phase III Anti-Insomnia Drug Trial | MT |
25/03 | Avecho Biotechnology Begins Patient Recruitment for Phase Three Anti-Insomnia Drug Trial | MT |
1st Jan change | Capi. | |
---|---|---|
-14.29% | 53.27L | |
+24.62% | 4.8TCr | |
+1.67% | 4.24TCr | |
+44.47% | 4.15TCr | |
+28.04% | 3.16TCr | |
+21.54% | 2.86TCr | |
-6.35% | 2.8TCr | |
+52.62% | 1.46TCr | |
+48.94% | 1.41TCr | |
+3.68% | 1.26TCr |
- Stock Market
- Equities
- AVE Stock
- News Avecho Biotechnology Limited
- Phosphagenics Limited Announces Change of Registered Office and Principal Place of Business